139 related articles for article (PubMed ID: 24135278)
1. Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.
Waning DL; Mohammad KS; Guise TA
Cancer Cell; 2013 Oct; 24(4):407-9. PubMed ID: 24135278
[TBL] [Abstract][Full Text] [Related]
2. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.
Ell B; Mercatali L; Ibrahim T; Campbell N; Schwarzenbach H; Pantel K; Amadori D; Kang Y
Cancer Cell; 2013 Oct; 24(4):542-56. PubMed ID: 24135284
[TBL] [Abstract][Full Text] [Related]
3. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
[No Abstract] [Full Text] [Related]
5. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
6. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
7. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous carbon dioxide application suppresses bone destruction caused by breast cancer metastasis.
Takemori T; Kawamoto T; Ueha T; Toda M; Morishita M; Kamata E; Fukase N; Hara H; Fujiwara S; Niikura T; Kuroda R; Akisue T
Oncol Rep; 2018 Oct; 40(4):2079-2087. PubMed ID: 30066936
[TBL] [Abstract][Full Text] [Related]
9. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration.
Franceschetti T; Kessler CB; Lee SK; Delany AM
J Biol Chem; 2013 Nov; 288(46):33347-60. PubMed ID: 24085298
[TBL] [Abstract][Full Text] [Related]
10. Regulation of breast cancer and bone metastasis by microRNAs.
Vimalraj S; Miranda PJ; Ramyakrishna B; Selvamurugan N
Dis Markers; 2013; 35(5):369-87. PubMed ID: 24191129
[TBL] [Abstract][Full Text] [Related]
11. Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.
Pollari S; Leivonen SK; Perälä M; Fey V; Käkönen SM; Kallioniemi O
PLoS One; 2012; 7(5):e37361. PubMed ID: 22629385
[TBL] [Abstract][Full Text] [Related]
12. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
Min Y; Ren X; Vaught DB; Chen J; Donnelly E; Lynch CC; Lin PC
Cancer Res; 2010 Apr; 70(7):2819-28. PubMed ID: 20233869
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-223 and miR-19a induces differentiation and promotes recruitment of osteoclast cells in giant-cell tumor of the bone via the Runx2/TWIST-RANK/RANKL pathway.
Jiang ZY; Jiang JJ; Ma YS; Li HY; Shi W; Fu PL; Xu CF; Lu JZ; Fu D; Xu JG
Biochem Biophys Res Commun; 2018 Nov; 505(4):1003-1009. PubMed ID: 30309658
[TBL] [Abstract][Full Text] [Related]
14. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis.
Clohisy DR; Palkert D; Ramnaraine ML; Pekurovsky I; Oursler MJ
J Orthop Res; 1996 May; 14(3):396-402. PubMed ID: 8676252
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
Nakamura H; Hiraga T; Ninomiya T; Hosoya A; Fujisaki N; Yoneda T; Ozawa H
J Bone Miner Metab; 2008; 26(6):642-7. PubMed ID: 18979165
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.
Kuo PL; Liao SH; Hung JY; Huang MS; Hsu YL
Biochim Biophys Acta; 2013 Jun; 1830(6):3756-66. PubMed ID: 23458685
[TBL] [Abstract][Full Text] [Related]
17. miR-31 controls osteoclast formation and bone resorption by targeting RhoA.
Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H
Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-124 regulates osteoclast differentiation.
Lee Y; Kim HJ; Park CK; Kim YG; Lee HJ; Kim JY; Kim HH
Bone; 2013 Oct; 56(2):383-9. PubMed ID: 23867221
[TBL] [Abstract][Full Text] [Related]
19. miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway.
Lou Z; Peng Z; Wang B; Li X; Li X; Zhang X
J Bone Miner Metab; 2019 Sep; 37(5):815-824. PubMed ID: 30900017
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases.
Li H; Zhai Z; Qu X; Xu J; Qin A; Dai K
Curr Drug Targets; 2018; 19(5):422-431. PubMed ID: 27138766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]